Valuation (19%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -43.12 | -19.88 |
| PEG Ratio (TTM) | 1.01 | -6.17 |
| P/S Ratio (TTM) | 176,909.93 | 46.12 |
| P/B Ratio (TTM) | 7.13 | 29.10 |
| P/FCF Ratio (TTM) | -43.06 | -4.71 |
| Price to 5YR AVG Earnings Ratio | N/A | -7.09 |
| Price to 5YR AVG FCF Ratio | N/A | -13.35 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -15.59% | -15.94% |
| ROE (TTM) | -15.78% | 26.46% |
| Net Profit Margin (TTM) | -409,200.94% | -619.38% |
| ROIC 5YR AVG | N/A | -10.12% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -42.72% | -37,298.83% | N/A |
| Revenue | -25.00% | N/A | N/A |
| Net Income | -46.52% | -19,643.41% | N/A |
| Cash Flow | -32.94% | -3,680.83% | N/A |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 25.51 | 5.65 |
| Quick Ratio (TTM) | 25.51 | 5.43 |
| D/E Ratio (TTM) | N/A | 0.98 |
| Interest Coverage (TTM) | N/A | -7.52 |
| Piotroski F-Score | 2 | 5 |
| Altman Z-Score | 92.36 | 12.65 |
| LTL to 5YR AVG FCF | N/A | 0.07 |
| Shares Outstanding Growth 5YR AVG | N/A | 38.42% |